Aligos Therapeutics, Inc.
ALGS
|
$0.8204
-0.39%
-0.39%
640K
|
Health Technology
(0.0% 1d) (-18.6% 1m) (-19.8% 1y) (0.0% 2d) (1.2% 3d) (10.7% 7d) (565.17% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 62,078,455
http://www.aligos.com
Sec Filling | Patents | 61 employees
Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.
covid nash treatment injection
add to watch list Paper trade email alert is off
Press-releases
Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: -0.96%
H: 6.8%
C: 2.91%
symposium biopharma spring therapeutics
Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
Published: 2024-04-03 (Crawled : 13:00) - biospace.com/
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: 2.25%
H: 4.0%
C: 1.0%
alg-0550 first therapeutics study
Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: -2.1%
alg-0550 alg-000184 positive therapeutics
Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: -1.25%
H: 4.4%
C: 1.1%
alg-0550 therapeutics study
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: 0.0%
H: 10.11%
C: 0.0%
business year therapeutics financial results
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: 1.05%
H: 4.91%
C: -3.0%
therapeutics financial results
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: 1.77%
H: 24.45%
C: 19.22%
conference biopharma global therapeutics
Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024
Published: 2024-02-20 (Crawled : 13:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: 2.94%
H: 6.11%
C: -4.38%
alg-0550 therapeutics study
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
CWBR | $0.9004 -11.88% 21
|
Health Technology
|
| O: 6.09%
H: 0.0%
C: -17.23%
CDNA | $7.995 -2.86% -2.94% 520K
|
Health Technology
|
| O: -7.39%
H: 2.74%
C: -5.24%
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: 1.47%
H: 1.45%
C: -7.54%
therapeutics
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)
Published: 2023-12-07 (Crawled : 21:00) - globenewswire.com
ALGS | $0.8204 -0.39% -0.39% 640K
|
Health Technology
|
| O: 4.62%
H: 5.15%
C: -14.71%
alg-0001 positive therapeutics nash
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10